With offices in Boston, MA, and Stockholm, Sweden, NuvoAir is a leading digital health company for chronic disease management and decentralized clinical trials. NuvoAir delivers a more continuous, relationship-based, coordinated and human-centric experience to individuals with complex conditions, with an initial focus on respiratory diseases. NuvoAir partners with health plans and risk-bearing providers with the goal to fully align incentives under a value-based care framework.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/19/22 | $25,000,000 | Series A |
Hikma Ventures | undisclosed |
